Ohio House Bill 263: Cap cost sharing for prescription insulin drugs, diabetes devices

Ohio · 2025-2026 Regular Session

What it does

To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.

Latest action

Referred to committee: Health (2025-05-14)

See how HB 263 affects you on CapitolKey

Browse more bills · CapitolKey home